Latest News for: bmn

Edit

BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ...

Lebanon Express 17 Jun 2026
Data from an investigator-led study showed treatment with VOXZOGO resulted in sustained improvements in growth over three years in children with hypochondroplasia ....
Edit

BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026

PR Newswire 16 Jun 2026
New Phase 1 results also presented for investigational BMN 333 support potential weekly dosing in children with achondroplasia ... New BMN 333 Phase 1 Data Support Advancement Into Late-Stage Development.
Edit

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ...

Montana Standard 19 May 2026
ENERGY 3 study met 1 of 2 co-primary endpoints in children with ENPP1 deficiency ... .
Edit

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency

PR Newswire 18 May 2026
BMRN) today announced results from the pivotal Phase 3 ENERGY 3 trial evaluating BMN 401 in children aged 1-12 with ENPP1 deficiency, a rare, serious and progressive genetic condition ... About BMN 401 and ENERGY 3.
Edit

Mike Epps Brings The Laughs Nationwide With “We Them Ones” 2026 Comedy Tour

The Source 15 Apr 2026
.
  • 1

Article Search

tools
×
×
×
×